Form 4: Zivo Bioscience Director Boosts Stake

Zivo Bioscience Director and 10% owner Laith L. Yaldoo acquired 1,659 shares of common stock at $12.05 per share.

Summary

• Laith L. Yaldoo, a Director and 10% owner of Zivo Bioscience, Inc. (ZIVO), reported the acquisition of common stock.
• The transaction involved the purchase of 1,659 shares of common stock at a price of $12.05 per share.
• The transaction date for this acquisition is October 10, 2025.
• Following this transaction, Laith L. Yaldoo beneficially owns 575,095 shares of common stock indirectly through HEP Investments LLC.
• The filing indicates the transaction was made pursuant to a Rule 10b5-1 plan.

Sentiment

Score: 7

Explanation: The sentiment is positive due to a significant insider (Director and 10% owner) increasing their stake in the company, indicating confidence in its future.

Positives

• A Director and 10% owner, Laith L. Yaldoo, increased his stake in the company, signaling confidence in Zivo Bioscience's future prospects.
• The purchase was made at a price of $12.05 per share, representing a direct investment by a key insider.

Future Outlook

The filing does not provide explicit forward-looking statements or guidance beyond the transaction details, but insider buying can be interpreted as a positive signal for future performance.

Industry Context

This insider transaction reflects a direct investment by a key stakeholder, which is generally viewed positively within the market as it suggests confidence in the company's strategy and valuation, irrespective of broader industry trends.

Related Party Transactions

• The beneficial ownership of 575,095 shares is held indirectly by HEP Investments LLC, which is likely a related entity given Laith L. Yaldoo's role as a 10% owner and Director.

Stakeholder Impact

• Shareholders: The purchase by a Director and 10% owner may instill greater confidence among existing and potential shareholders, signaling strong internal belief in the company's value.

Key Dates

Recommendation

The acquisition of shares by a Director and 10% owner, Laith L. Yaldoo, is a strong positive signal. Insider buying often indicates that those with the most intimate knowledge of the company believe its stock is undervalued or that significant positive developments are anticipated. This action suggests management confidence and could be a catalyst for positive investor sentiment, warranting a 'buy' recommendation.

Keywords

Zivo Bioscience, ZIVO, insider trading, Form 4, stock purchase, director, 10% owner, Laith L. Yaldoo, Rule 10b5-1